Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | STAT6 | P42226 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 4/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL22129962 | 0.98 | MAPK1 (0.33) | MAPK1LMNASMN1; SMN2TP53NFKB1 | |
| Fluoride SCHEMBL23795544 | 0.98 | MAPK1 (0.33) | MAPK1LMNASMN1; SMN2TP53NFKB1 | |
| Fluoride SCHEMBL23795550 | 0.98 | MAPK1 (0.33) | MAPK1LMNASMN1; SMN2TP53NFKB1 | |
| SCHEMBL16796676 | 0.98 | MAPK1 (0.35) | MAPK1LMNASMN1; SMN2TP53NFKB1 | |
| SCHEMBL28678942 | 0.96 | MAPK1 (0.34) | MAPK1LMNASMN1; SMN2TP53NFKB1 | |
| SCHEMBL28596043 | 0.96 | MAPK1 (0.34) | MAPK1LMNASMN1; SMN2TP53NFKB1 | |
| SCHEMBL20581981 | 0.83 | MAPK1 (0.36) | MAPK1LMNASMN1; SMN2TP53NFKB1 | |
| SCHEMBL20054634 | 0.83 | MAPK1 (0.36) | MAPK1LMNASMN1; SMN2TP53NFKB1 | |
| SCHEMBL22127645 | 0.83 | MAPK1 (0.36) | MAPK1LMNASMN1; SMN2TP53NFKB1 | |
| SCHEMBL20054632 | 0.83 | MAPK1 (0.36) | MAPK1LMNASMN1; SMN2TP53NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3878845-B1 | PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) PRODUCTION METHOD | TOSOH CORP (JP) | 2023-06-21 | — | — | EP | claimed |
| US-20220002262-A1 | METHOD OF PRODUCING PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) | TOSOH CORPORATION (JP) | 2022-01-06 | — | — | US | claimed |
| EP-3878845-A1 | PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) PRODUCTION METHOD | Tosoh Corporation (JP) | 2021-09-15 | — | — | EP | claimed |
| US-20250382275-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING DIOXOLANE, AND COMPOSITION USEFUL FOR PRODUCING SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2025-12-18 | — | — | US | disclosed |
| EP-3878845-B1 | PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) PRODUCTION METHOD | TOSOH CORP (JP) | 2023-06-21 | — | — | EP | disclosed |
| WO-2023033073-A1 | PRODUCTION METHOD FOR FLUORINE-CONTAINING DIOXOLANE AND COMPOSITION USEFUL FOR PRODUCTION OF SAME | ダイキン工業株式会社 | 2023-03-09 | — | — | WO | disclosed |
| US-20220002262-A1 | METHOD OF PRODUCING PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) | TOSOH CORPORATION (JP) | 2022-01-06 | — | — | US | disclosed |
| US-20220002262-A1 | METHOD OF PRODUCING PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) | TOSOH CORPORATION (JP) | 2022-01-06 | — | — | US | disclosed |
| EP-3878845-A1 | PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) PRODUCTION METHOD | Tosoh Corporation (JP) | 2021-09-15 | — | — | EP | disclosed |
| EP-3878845-A1 | PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) PRODUCTION METHOD | Tosoh Corporation (JP) | 2021-09-15 | — | — | EP | disclosed |
| WO-2020095915-A1 | PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) PRODUCTION METHOD | 東ソ－株式会社 | 2020-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220002262-A1 | METHOD OF PRODUCING PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) | AFF1, AFF2, AFF4 | MAPK1 2332/4885LMNA 1121/4885SMN1; SMN2 1697/4885 |
| US-20250382275-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING DIOXOLANE, AND COMPOSITION USEFUL FOR PRODUCING SAME | AFF1, HAO2, F9 | MAPK1 1301/4885LMNA 531/4885SMN1; SMN2 1597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.